301 related articles for article (PubMed ID: 20515425)
21. Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis.
Singh D; Verma R; Garg RK; Singh MK; Shukla R; Verma SK
J Neurol Sci; 2011 Jul; 306(1-2):76-81. PubMed ID: 21496826
[TBL] [Abstract][Full Text] [Related]
22. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis.
Pinto S; de Carvalho M
Muscle Nerve; 2008 Oct; 38(4):1312-7. PubMed ID: 18785186
[TBL] [Abstract][Full Text] [Related]
23. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.
de Carvalho M; Scotto M; Lopes A; Swash M
Muscle Nerve; 2003 Nov; 28(5):630-3. PubMed ID: 14571468
[TBL] [Abstract][Full Text] [Related]
24. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
25. Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit.
Rodríguez de Rivera FJ; Oreja Guevara C; Sanz Gallego I; San José Valiente B; Santiago Recuerda A; Gómez Mendieta MA; Arpa J; Díez Tejedor E
Neurologia; 2011 Oct; 26(8):455-60. PubMed ID: 21419529
[TBL] [Abstract][Full Text] [Related]
26. [Respiratory domain of revised amyotrophic lateral sclerosis. Functional Rating Scale].
Lima SE; Pessolano FA; Monteiro SG; De Vito EL
Medicina (B Aires); 2009; 69(5):547-53. PubMed ID: 19897441
[TBL] [Abstract][Full Text] [Related]
27. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
[TBL] [Abstract][Full Text] [Related]
28. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study.
de Carvalho M; Swash M
Muscle Nerve; 2010 Feb; 41(2):208-11. PubMed ID: 19697379
[TBL] [Abstract][Full Text] [Related]
30. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
Desport JC; Marin B; Funalot B; Preux PM; Couratier P
Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
[TBL] [Abstract][Full Text] [Related]
31. MRI predictors of long-term evolution in amyotrophic lateral sclerosis.
Agosta F; Pagani E; Petrolini M; Sormani MP; Caputo D; Perini M; Prelle A; Salvi F; Filippi M
Eur J Neurosci; 2010 Nov; 32(9):1490-6. PubMed ID: 21044177
[TBL] [Abstract][Full Text] [Related]
32. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study.
Nefussy B; Artamonov I; Deutsch V; Naparstek E; Nagler A; Drory VE
Amyotroph Lateral Scler; 2010; 11(1-2):187-93. PubMed ID: 19449238
[TBL] [Abstract][Full Text] [Related]
34. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
35. Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis.
Nair G; Carew JD; Usher S; Lu D; Hu XP; Benatar M
Neuroimage; 2010 Nov; 53(2):576-83. PubMed ID: 20600964
[TBL] [Abstract][Full Text] [Related]
36. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.
Jawaid A; Murthy SB; Wilson AM; Qureshi SU; Amro MJ; Wheaton M; Simpson E; Harati Y; Strutt AM; York MK; Schulz PE
Amyotroph Lateral Scler; 2010 Dec; 11(6):542-8. PubMed ID: 20500116
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis.
Higo R; Tayama N; Nito T
Auris Nasus Larynx; 2004 Sep; 31(3):247-54. PubMed ID: 15364359
[TBL] [Abstract][Full Text] [Related]
38. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
[TBL] [Abstract][Full Text] [Related]
39. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.
Reich-Slotky R; Andrews J; Cheng B; Buchsbaum R; Levy D; Kaufmann P; Thompson JL
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):212-6. PubMed ID: 23452274
[TBL] [Abstract][Full Text] [Related]
40. Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.
De Groot IJ; Post MW; van Heuveln T; Van den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2007 Dec; 8(6):356-61. PubMed ID: 18033593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
